Artificial Intelligence (AI) is transforming nearly all aspects of clinical research, from accelerating study timelines to enabling smarter trial design and execution. As AI becomes embedded across the drug development lifecycle, the roles of programmers and biostatisticians are evolving alongside it.

What is changing? What isn’t? And what will it take to maximize your impact on an AI-enabled future?

In this webinar, Cytel’s FSP leaders will explore how AI is influencing programming and biostatistics in clinical development, where human expertise remains indispensable, and what the future may hold for these critical disciplines. Drawing on our experience leading global programming and biostatistics teams, we will share our perspective on the opportunities, challenges, and skills that will shape the next generation of clinical development.

Key Topics: 

• AI’s unique impact on clinical development 

• What AI is and is not changing for programmers and biostatisticians 

• The evolution of these roles in an AI-enabled future 

• Preparing individuals and sponsors for what’s next 

Speakers: 

• Ashik Chowdhury, Director, FSP Operations 

• Peggy Schrammel, Vice President, FSP Operations